The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Effect of Clopidogrel on Early Failure of Arteriovenous Fistulas for Hemodialysis: A Randomized Controlled Trial
Open accessAbstract
CONTEXT: The arteriovenous fistula is the preferred type of vascular access for hemodialysis because of lower thrombosis and infection rates and lower health care expenditures compared with synthetic grafts or central venous catheters. Early failure of fistulas due to thrombosis or inadequate maturation is a barrier to increasing the prevalence of fistulas among patients treated with hemodialysis. Small, inconclusive trials have suggested that antiplatelet agents may reduce thrombosis of new fistulas. OBJECTIVE: To determine whether clopidogrel reduces early failure of hemodialysis fistulas. DESIGN, SETTING, AND PARTICIPANTS: Randomized, double-blind, placebo-controlled trial conducted at 9 US centers composed of academic and community nephrology practices in 2003-2007. Eight hundred seventy-seven participants with end-stage renal disease or advanced chronic kidney disease were followed up until 150 to 180 days after fistula creation or 30 days after initiation of dialysis, whichever occurred later. INTERVENTION: Participants were randomly assigned to receive clopidogrel (300-mg loading dose followed by daily dose of 75 mg; n = 441) or placebo (n = 436) for 6 weeks starting within 1 day after fistula creation. MAIN OUTCOME MEASURES: The primary outcome was fistula thrombosis, determined by physical examination at 6 weeks. The secondary outcome was failure of the fistula to become suitable for dialysis. Suitability was defined as use of the fistula at a dialysis machine blood pump rate of 300 mL/min or more during 8 of 12 dialysis sessions. RESULTS: Enrollment was stopped after 877 participants were randomized based on a stopping rule for intervention efficacy. Fistula thrombosis occurred in 53 (12.2%) participants assigned to clopidogrel compared with 84 (19.5%) participants assigned to placebo (relative risk, 0.63; 95% confidence interval, 0.46-0.97; P = .018). Failure to attain suitability for dialysis did not differ between the clopidogrel and placebo groups (61.8% vs 59.5%, respectively; relative risk, 1.05; 95% confidence interval, 0.94-1.17; P = .40). CONCLUSION: Clopidogrel reduces the frequency of early thrombosis of new arteriovenous fistulas but does not increase the proportion of fistulas that become suitable for dialysis. Trial Registration clinicaltrials.gov Identifier: NCT00067119.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Statistical Aspects of the Analysis of Data From Retrospective Studies of Disease
(1959) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/22.4.719 · Cited by 14,689
Clinical Practice Guidelines for Vascular Access
(2006) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2006.04.040 · Cited by 1,593
Group Sequential Methods with Applications to Clinical Trials
Jennison, C., & Turnbull, B. W. (1999) · Chapman & Hall/CRC eBooks · doi:10.1201/9780367805326 · Cited by 1,336
Increasing arteriovenous fistulas in hemodialysis patients: Problems and solutions
Allon, M., & Robbin, M. L. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00551.x · Cited by 763
Self-citationGroup Sequential Methods with Applications to Clinical Trials
Kim, K. (2001) · Controlled Clinical Trials · doi:10.1016/s0197-2456(00)00127-6 · Cited by 706
Hemodialysis vascular access morbidity.
Feldman, H. I., Kobrin, S., & Wasserstein, A. (1996) · Journal of the American Society of Nephrology · doi:10.1681/asn.v74523 · Cited by 667
Self-citationAggressive treatment of early fistula failure
Beathard, G. A., Arnold, P., Jackson, J., Litchfield, T., & Lifeline, P. O. F. O. R. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00210.x · Cited by 463
Salvage of immature forearm fistulas for haemodialysis by interventional radiology
Turmel‐Rodrigues, L., Mouton, A., Birmelé, B., Billaux, L., Ammar, N., Grézard, O., Hauss, S., & Pengloan, J. (2001) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/16.12.2365 · Cited by 242
Ohira, S., Naito, H., Amano, I., Azuma, N., Ikeda, K., Kukita, K., Goto, Y., Sakai, S., Shinzato, T., Sugimoto, T., et al. (2006) · Therapeutic Apheresis and Dialysis · doi:10.1111/j.1744-9987.2006.00410.x · Cited by 201
Maintenance and Salvage of Arteriovenous Fistulas
Falk, A. (2006) · Journal of Vascular and Interventional Radiology · doi:10.1097/01.rvi.0000217928.43396.35 · Cited by 168
Balancing Fistula First With Catheters Last
Lacson, E., Lazarus, J. M., Himmelfarb, J., Ikizler, T. A., & Hakim, R. M. (2007) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2007.06.006 · Cited by 156
Self-citationAndrássy, K., Malluche, H. H., Bornefeld, H., Comberg, M., Ritz, E., Jesdinsky, H. J., & M�hring, K. (1974) · Journal of Molecular Medicine · doi:10.1007/bf01468835 · Cited by 71
Effects of Ticlopidine in AV-fistula Surgery in Uremia
Gröntoft, R. L. K.-C. (1998) · Scandinavian Journal of Urology and Nephrology · doi:10.1080/003655998750015458 · Cited by 65
Thromboprophylactic Effect of Ticlopidine in Arteriovenous Fistulas for Haemodialysis
Gröntoft, K., Mulec, H., Gutierrez, A., & Olander, R. (1985) · Scandinavian Journal of Urology and Nephrology · doi:10.3109/00365598509180223 · Cited by 60
FISKERSTRAND, C. E., Thompson, I. W., Burnet, M. E., Williams, P., & Anderton, J. L. (1985) · Artificial Organs · doi:10.1111/j.1525-1594.1985.tb04349.x · Cited by 57
Antithrombotic Agents and the Prevention of Access Thrombosis
Kaufman, J. S. (2000) · Seminars in Dialysis · doi:10.1046/j.1525-139x.2000.00012.x · Cited by 30
Self-citationStatistical Analyses of the Relative Risk
Gart, J. J. (1979) · Environmental Health Perspectives · doi:10.1289/ehp.7932157 · Cited by 20
Cited by
KDOQI Clinical Practice Guideline for Vascular Access: 2019 Update
Lok, C. E., Huber, T. S., Lee, T., Shenoy, S., Yevzlin, A. S., Abreo, K., Allon, M., Asif, A., Astor, B. C., Glickman, M. H., et al. (2020) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2019.12.001 · Cited by 2,590
Self-citationHofstra, L., Tordoir, J. H. M., Kitslaar, P. J. E. H. M., Hoeks, A. P. G., & Daemen, M. J. A. P. (1996) · Circulation · doi:10.1161/01.cir.94.6.1283 · Cited by 1,603
Associations between Hemodialysis Access Type and Clinical Outcomes: A Systematic Review
Ravani, P., Palmer, S. C., Oliver, M. J., Quinn, R. R., MacRae, J. M., Tai, D. J., Pannu, N. I., Thomas, C., Hemmelgarn, B. R., Craig, J. C., et al. (2013) · Journal of the American Society of Nephrology · doi:10.1681/asn.2012070643 · Cited by 738
Patency Rates of the Arteriovenous Fistula for Hemodialysis: A Systematic Review and Meta-analysis
Al-Jaishi, A. A., Oliver, M. J., Thomas, S. M., Lok, C. E., Zhang, J. C., Garg, A. X., Kosa, S. D., Quinn, R. R., & Moist, L. M. (2014) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2013.08.023 · Cited by 680
Sidawy, A. N., Spergel, L. M., Besarab, A., Allon, M., Jennings, W. C., Padberg, F. T., Murad, M. H., Montori, V. M., O'Hare, A. M., Calligaro, K. D., et al. (2008) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2008.08.042 · Cited by 553
Self-citation
Metadata
- Authors
- Dember, L. M., Beck, G. J., Allon, M., Delmez, J. A., Dixon, B. S., Greenberg, A., Himmelfarb, J., Vazquez, M. A., Gassman, J. J., Greene, T., Radeva, M. K., Braden, G. L., Ikizler, T. A., Rocco, M. V., Davidson, I. J., Kaufman, J. S., Meyers, C. M., Kusek, J. W., Feldman, H. I., & Dialysis Access Consortium Study Group, F. T.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2008-05-14
- Volume
- 299
- Issue
- 18
- Pages
- 2164
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2073772081
- Cited by
- 826
- References
- 17
- FWCI
- 68.20
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.